REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 218 filers reported holding REATA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $439,506 | -36.8% | 11,569 | -49.4% | 0.03% | +4.0% |
| Q2 2022 | $695,000 | -20.6% | 22,877 | -14.4% | 0.02% | -26.5% |
| Q1 2022 | $875,000 | +32.0% | 26,724 | +6.4% | 0.03% | +13.3% |
| Q4 2021 | $663,000 | -46.9% | 25,128 | +190.6% | 0.03% | -66.7% |
| Q1 2020 | $1,248,000 | -6.2% | 8,647 | -63.6% | 0.09% | -15.9% |
| Q4 2018 | $1,331,000 | -59.4% | 23,727 | -40.9% | 0.11% | -57.5% |
| Q3 2018 | $3,280,000 | +290.0% | 40,114 | +66.8% | 0.25% | +281.8% |
| Q2 2018 | $841,000 | – | 24,043 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |